A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

NCT04524403 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Antipsychotic-induced Weight Gain (AIWG)

Interventions

DRUG: Miricorlilant
DRUG: Miricorlilant
DRUG: Placebo

Sponsor

Corcept Therapeutics